mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Parthenolide |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.002 |
mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
Cerulenin |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.004 |
mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.088 |
0.008 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.008 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.008 |